Literature DB >> 11133330

Measles epidemic in Israel-successful containment in the military.

M Gdalevich1, M Ephros, D Mimouni, I Grotto, O Shpilberg, A Eldad, I Ashkenazi.   

Abstract

BACKGROUND: Measles vaccination at ages 12-15 months is a routine part of standard health care in developed countries. Nonetheless, the prevention and control of measles outbreaks remain a challenge, owing to incomplete or variable compliance with immunization programs and primary vaccine failure (approximately 5%). In Israel, vaccination coverage against measles is high, yet sero-epidemiological studies conducted in the early 1990s showed that 15% of 18-year-olds were unprotected.
METHODS: 1994 there was a countrywide epidemic of measles, which spread to the military. The Israel Defense Forces Medical Corps immediately launched a wide-scale vaccination campaign, targeting primarily field units and training bases, where crowded living conditions are the rule.
RESULTS: The immunization campaign led to an abrupt cessation of morbidity in the military. In the civilian sector, where no intervention was undertaken, the epidemic continued for another 4 months.
CONCLUSIONS: Institutional measles outbreaks, especially in the presence of crowded conditions or high contact rates, may be effectively controlled by mass vaccination. Copyright 2000 American Health Foundation and Academic Press.

Mesh:

Substances:

Year:  2000        PMID: 11133330     DOI: 10.1006/pmed.2000.0757

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  2 in total

1.  Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.

Authors:  Hagai Levine; Salman Zarka; Omer E Ankol; Vladi Rozhavski; Nadav Davidovitch; Yair Aboudy; Ran D Balicer
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs.

Authors:  Carmit Rapaport; Isaac Ashkenazi
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.